Khorana Score: A Potential New Biomarker for Real Life Non-Small Cell Lung Cancer (NSCLC) Patients Treated with Immunotherapy

被引：0
|
作者：
Bjornhart, B. [1 ]
Hansen, K. [2 ]
Jorgensen, T. [3 ]
Herrstedt, J. [4 ]
Schytte, T. [1 ]
机构：
[1] Univ Southern Denmark, Dept Clin Res, Odense, Denmark
[2] Odense Univ Hosp, Oncol, Odense C, Denmark
[3] Acad Geriatr Canc Res Agecare, Clin Oncol, Odense, Denmark
[4] Zealand Univ Hosp, Clin Oncol, Roskilde, Denmark
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
Biomarker; Non small cell lung cancer; Checkpoint inhibitors;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP1.04-29
引用
收藏
页码：S980 / S981
页数：2
相关论文
共 50 条
  • [31] Circulating tumor DNA (ctDNA)-the next generation biomarker in non-small cell lung cancer patients treated with immunotherapy?
    Hydbring, Per
    TRANSLATIONAL LUNG CANCER RESEARCH, 2024, 13 (09) : 2103 - 2105
  • [32] Immunotherapy in Advanced Non-Small Cell Lung Cancer Previously Treated: Real World Data
    Ferreira Pereira, F.
    Lopes, A. R.
    Cruz, A.
    Cassiano, M.
    Rosinha, A.
    Oliveira, C.
    Rodrigues, A.
    Oliveira, J.
    Pousa, I.
    Azevedo, I.
    Soares, M.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S973 - S974
  • [33] Non-small cell lung cancer (NSCLC) in elderly patients
    Batura-Gabryel, H.
    Brajer, B.
    LUNG CANCER, 2006, 52 : S19 - S19
  • [34] Immunotherapy causing pneumonitis in a patient with non-small cell lung cancer (NSCLC)
    Li, Rui
    Lee, Gina
    El-Sherief, Ahmed
    BMJ CASE REPORTS, 2019, 12 (03)
  • [35] Implementation of immunotherapy in the treatment of advanced non-small cell lung cancer (NSCLC)
    Tsiara, Anna
    Liontos, Michalis
    Kaparelou, Maria
    Zakopoulou, Roubini
    Bamias, Aristotelis
    Dimopoulos, Meletios-Athanasios
    ANNALS OF TRANSLATIONAL MEDICINE, 2018, 6 (08)
  • [36] Immunotherapy and Vaccination in Surgically Resectable Non-Small Cell Lung Cancer (NSCLC)
    Chiu, Li-Chung
    Lin, Shu-Min
    Lo, Yu-Lun
    Kuo, Scott Chih-Hsi
    Yang, Cheng-Ta
    Hsu, Ping-Chih
    VACCINES, 2021, 9 (07)
  • [37] Obesity Paradox in Patients With Non-Small Cell Lung Cancer Treated With Immunotherapy Reply
    Kichenadasse, Ganessan
    Hopkins, Ashley M.
    Sorich, Michael J.
    JAMA ONCOLOGY, 2020, 6 (06) : 941 - +
  • [38] Prognostic Factors in Advanced Non-Small Cell Lung Cancer Patients Treated with Immunotherapy
    Rocco, Danilo
    Della Gravara, Luigi
    Ragone, Angela
    Sapio, Luigi
    Naviglio, Silvio
    Gridelli, Cesare
    CANCERS, 2023, 15 (19)
  • [39] Real-world outcomes after second-line treatment in non-small cell lung cancer (NSCLC) patients treated with immunotherapy.
    Maramarelis, Melina Elpi
    Hwang, Wei-Ting
    Yang, Tu-Xiao
    Ciunci, Christine Agnes
    Singh, Aditi Puri
    Aggarwal, Charu
    Cohen, Roger B.
    Langer, Corey J.
    Mamtani, Ronac
    Bauml, Joshua
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [40] Immuntherapie des nichtkleinzelligen Lungenkarzinoms (NSCLC)Immunotherapy for non-small cell lung cancer (NSCLC)
    Nikolaj Frost
    Martin Reck
    Die Innere Medizin, 2022, 63 (7) : 709 - 716
12345